Pipeline · Bill → Law
Step 1
Introduced
Jul 13, 2022
Step 2
Referred
Jul 13, 2022
Ways & Means
Step 3
Committee
Jul 13, 2022
Step 4
House floor
Step 5
Senate
Jul 21, 2022
Passed Senate
Step 6
Resolve Changes
Step 7
Signed
Jul 21, 2022
SummaryCRS Summary
This bill provides through December 31, 2022, duty-free treatment to infant formula. During this time period, articles of infant formula shall not be subject to (1) any additional safeguard duties that may be imposed under subchapter IV of chapter 99 of the Harmonized Tariff Schedule; or (2) any other import quotas, tariff-rate quotas, additional duties, or any other duties, fees, exactions, or charges that otherwise would apply to such articles. Importers shall provide the applicable and anticipated tariff classifications for articles of infant formula on applicable customs entry documents.
Similar Bills · 1 matches
| Bill | Text overlap | Status |
|---|---|---|
| H.R. 8174— Affordable and Accessible Infant Formula Act | 79% | INCORPORATED |
Roll Call Votes · 1
Timeline · 15 actions
Jul 21, 2022
Passed Senate without amendment by Voice Vote.
Jul 21, 2022
Message on Senate action sent to the House.
Jul 21, 2022
Presented to President.
Jul 21, 2022
Signed by President.
Jul 21, 2022
Became Public Law No: 117-160.
Jul 19, 2022
Received in the Senate, read twice.
Jul 15, 2022
Mr. Blumenauer moved to suspend the rules and pass the bill.
Jul 15, 2022
Considered under suspension of the rules.
Jul 15, 2022
DEBATE - The House proceeded with forty minutes of debate on H.R. 8351.
Jul 15, 2022
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Jul 15, 2022
Considered as unfinished business.
Jul 15, 2022
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 421 - 2 (Roll no. 363).ROLL CALLpass
Jul 15, 2022
Motion to reconsider laid on the table Agreed to without objection.
Jul 13, 2022
Introduced in House
Jul 13, 2022
Referred to the House Committee on Ways and Means.